Company: IXHL
Filing Date: 2025-10-27
Form Type: DEF 14A
Source: 0001213900-25-102654
Chunk: 17

Company: Incannex Healthcare Inc.
Filing Date: 2025-10-27
Form: DEF 14A
Chunk 17
---
 directors for approval and periodically reviewing these criteria. These membership criteria include leadership experience, financial expertise and industry knowledge. The board of directors believes that the independent directors can satisfactorily carry out these responsibilities without the formation of a standing nominating and corporate governance committee. The board of directors evaluates its composition annually to assess the skills and experience currently represented on the board of directors as a whole, and in individual directors, as well as the skills and experience that the board of directors may find valuable in the future. The board of directors actively seeks to achieve a diversity of occupational and personal backgrounds amongst members of the board of directors, including diversity with respect to demographics such as gender, race, ethnic and national background, geography, age and sexual orientation. The independent directors must review the qualifications of director candidates and incumbent directors in light of criteria approved by the board of directors and recommend candidates to the board of directors for election by the Company’s stockholders at the Annual Meeting. Our Principles of Corporate Governance are publicly available on our website at www.incannex.com. 11 The independent members of our board of directors will consider stockholder nominations. If a stockholder wishes to propose a candidate for consideration as a nominee for election to our board of directors, it must follow the procedures described in our bylaws and in “ Stockholder Proposals and Nominations for Director” at the end of this proxy statement. Any such recommendation should be made in writing to our board of directors, care of our Secretary at our principal office and should be accompanied by the information required by our bylaws, including among other things, the following information concerning each recommending stockholder and the beneficial owner, if any, on whose behalf the nomination is made:

| ● | all information relating to such person that would be required 
 to be disclosed in a proxy statement;                          |

| ● | certain biographical and share ownership information about the                                                           
 stockholder and any other proponent, including a description of any derivative transactions in the Company’s securities; |

| ● | a description of certain arrangements and understandings between                                                            
 the proposing stockholder and any beneficial owner and any other person in connection with such stockholder nomination; and |

| ● | a statement whether or not either such stockholder or beneficial                                                           
 owner intends to deliver a proxy statement and form of proxy to holders of voting shares sufficient to carry the proposal. |

The recommendation must also be accompanied by the following information concerning the proposed nominee:

| ● | a statement that the nominee consents to be named in the registrant’s